Systematic analysis and in vitro experiment confirmed that high expression of ACSL4 predicted a worse prognosis in colorectal cancer and downregulating ACSL4 could reduce cell proliferation and invasion (Chen et al., 2016). The gene discussed is ACSL4; the disease is colorectal cancer.